# Commission Implementing Decision (EU) 2018/945 of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions (Text with EEA relevance), Division: Laboratory Criteria (HIV)

Extent: E+W+S+N.I.

Adults, adolescents and children aged ≥ 18 months
At least one of the following three:
Positive result of a HIV screening antibody test or a combined screening test (HIV antibody and HIV p24 antigen) confirmed by a more specific antibody test (for example, Western blot);
Positive result of 2 EIA antibody test confirmed by a positive result of a further EIA test;
Positive results on two separate specimens from at least one of the following three:
Detection of HIV nucleic acid (HIV-RNA, HIV-DNA);
Demonstration of HIV by HIV p24 antigen test, including neutralisation assay;
Isolation of HIV.
Children aged < 18 months
Positive results on two separate specimens (excluding cord blood) from at least one of the following three:
Isolation of HIV;
Detection of HIV nucleic acid (HIV-RNA, HIV-DNA);
Demonstration of HIV by HIV p24 antigen test, including neutralisation assay in a child ≥ 1 month of age.

---
Source: https://www.legislation.gov.uk/eudn/2018/945/annex/II/division/3/division/3.19/division/2 (the official version)
Page: https://openlegislation.uk/eu-decision-2018-945/annex-II/division-3/division-3.19/division-2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.